Lantheus Holdings, Inc. (NASDAQ:LNTH – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among brokerages […]
Forefront Analytics LLC grew its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 67.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 33,685 shares of the company’s stock after buying an additional 13,610 shares during the period. Forefront Analytics LLC’s holdings in […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report)’s share price hit a new 52-week high on Thursday . The stock traded as high as $10.64 and last traded at $10.30, with a volume of 223577 shares changing hands. The stock had previously closed at $10.03. Analysts Set New Price Targets A number of equities research […]
Lantheus (NASDAQ:LNTH) Shares Down 3.1% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Purchased by Sector Gamma AS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.